Insurer access challenges likely lie ahead for the novel schizophrenia drug Cobenfy, given its considerably higher price than ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Bristol-Myers Squibb (BMY – Research Report) and Envista ...

Bristol Myers Squibb's revenue was fueled by Growth Portfolio and Eliquis. Analysts anticipate an impact from Cobenfy and a ...

BofA raised the firm’s price target on Bristol Myers (BMY) to $60 from $55 and keeps a Neutral rating on the shares. Bristol reported ...

Bristol Myers Squibb's (BMY) new schizophrenia drug, Cobenfy, improves symptoms with a well-tolerated safety profile in two ...

Some people who took a new schizophrenia drug for a year improved with only a few side effects, but many dropped out of the research, the company announced Thursday.

Outside the accident and emergency department in Coventry is a man in a wheelchair. He is in a pitiful state. His legs and feet are swollen, causing him intense pain, but more than anything else ...

Preston North End heaped further misery on out-of-form Coventry City with a narrow 1-0 Championship win at Deepdale. Centre forward Emil Riis' 72nd-minute goal was enough to separate the sides and ...

Emil Riis ensured Preston's unbeaten home record under Paul Heckingbottom continued as the Lilywhites beat Coventry 1-0 in the Sky Bet Championship. The 26-year-old headed home a 72nd-minute ...

They did arrive back at different times, so Coventry have had to manage that dynamic. Jake Bidwell will be missing, but the defender’s injury is not as bad as the Sky Blues initially feared.

In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other best medical stocks to buy now. The medical and healthcare industry is one of the ...

Based in New York, New York, Bristol-Myers Squibb Company (BMY) is a global biopharmaceutical leader focused on discovering, developing, and delivering innovative medicines. With a market cap of $ ...